GlassScriptPhysician profile
Gautum Agarwal
NPI 1780880633
$11,991.13
in general payments reported to CMS, 2019-2025
69 companies · $3,825 in 2025
The $3,825 reported for 2025 was more than what 89% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,502 · 2020: $102 · 2021: $1,208 · 2022: $1,070 · 2023: $1,606 · 2024: $2,680 · 2025: $3,825.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,893 · Consulting Fee: $3,090 · Travel and Lodging: $1,027 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,893.45 |
| Consulting Fee | $3,090.00 |
| Travel and Lodging | $1,027.01 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $2,972.25 | 2019-2025 | Erleada, Balversa, Akeega |
| Coloplast Corp | $886.75 | 2021-2025 | Speedicath, Sensura Mio, Titan |
| Tempus Ai, INC | $882.15 | 2024 | |
| Histosonics, INC. | $661.13 | 2024 | |
| Procept Biorobotics Corporation | $618.18 | 2022-2024 | Aquabeam Robotic System, Aquabeam System |
| Boston Scientific Corporation | $596.64 | 2019-2025 | General - Kidney Stone Disease, Ams 700 Cxr Rte Kit, Spaceoar Vue System - 10ml |
| Astellas Pharma US INC | $577.34 | 2019-2025 | Padcev, Xtandi |
| Merck Sharp & Dohme LLC | $413.68 | 2021-2025 | Keytruda, Welireg, Lynparza |
| Abbvie INC. | $310.60 | 2021-2025 | Botox |
| Conmed Corporation | $300.00 | 2019 | |
| Emd Serono, INC. | $280.62 | 2022-2025 | Bavencio |
| Allergan, INC. | $273.95 | 2019-2022 | |
| Intuitive Surgical, INC. | $244.30 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $240.15 | 2019-2025 | |
| Urogen Pharma, INC. | $185.45 | 2021-2025 | Jelmyto |
Show all 67 companies
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gautum Agarwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.